RP Management, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Quarter-by-quarter ownership
RP Management, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$167,967,000
+3.7%
1,111,1110.0%77.60%
+21.4%
Q2 2022$161,900,000
+22.9%
1,111,1110.0%63.94%
+19.3%
Q1 2022$131,744,000
-14.0%
1,111,1110.0%53.58%
-16.4%
Q4 2021$153,122,000
-0.8%
1,111,1110.0%64.09%
-11.0%
Q3 2021$154,344,000
+43.1%
1,111,1110.0%72.03%
+37.0%
Q2 2021$107,867,000
-25.2%
1,111,111
-47.4%
52.60%
-2.9%
Q1 2021$144,294,000
-20.3%
2,111,1110.0%54.16%
-2.4%
Q4 2020$180,943,000
+31.8%
2,111,1110.0%55.51%
+169.9%
Q3 2020$137,243,000
-11.1%
2,111,1110.0%20.57%
-31.1%
Q2 2020$154,343,000
+114.8%
2,111,1110.0%29.83%
+33.8%
Q1 2020$71,841,000
-37.5%
2,111,1110.0%22.30%
-14.2%
Q4 2019$114,923,000
+30.5%
2,111,1110.0%25.98%
-53.9%
Q3 2019$88,076,000
-4.7%
2,111,1110.0%56.42%
-0.5%
Q2 2019$92,446,000
-14.9%
2,111,1110.0%56.70%
+4.3%
Q1 2019$108,659,000
+39.2%
2,111,1110.0%54.35%
+1.7%
Q4 2018$78,069,0002,111,11153.45%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 896,844$123,594,00067.92%
RP Management, LLC 1,111,111$153,122,00064.09%
ORACLE INVESTMENT MANAGEMENT INC 2,075,402$286,011,00040.64%
ARS Investment Partners, LLC 463,392$63,860,0005.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 300,373$41,394,0004.76%
SILVERARC CAPITAL MANAGEMENT, LLC 80,348$11,073,0004.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,900$19,282,0004.30%
Avidity Partners Management LP 1,140,000$157,103,0003.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$27,562,0003.17%
Eventide Asset Management 1,635,000$225,319,0002.88%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders